These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2985254)

  • 1. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
    Neuwelt EA; Frenkel EP; D'Agostino AN; Carney DN; Minna JD; Barnett PA; McCormick CI
    Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
    Cosolo W; Christophidis N
    Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats: antidrug antibody to achieve systemic drug rescue.
    Kroll RA; Pagel MA; Langone JJ; Sexton GJ; Neuwelt EA
    Ther Immunol; 1994 Dec; 1(6):333-41. PubMed ID: 7584509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antigenic heterogeneity on the efficacy of enhanced delivery of antibody-targeted chemotherapy in a human lung cancer intracerebral xenograft model in rats.
    Muldoon LL
    Neurosurgery; 2003 Dec; 53(6):1406-12; discussion 1412-3. PubMed ID: 14633307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
    Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
    Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
    Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
    Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.
    Neuwelt EA; Barnett PA; McCormick CI; Remsen LG; Kroll RA; Sexton G
    Clin Cancer Res; 1998 Jun; 4(6):1549-55. PubMed ID: 9626476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New developments in chemotherapy for experimental brain metastasis].
    Kobayashi T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):757-65. PubMed ID: 3157350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B and the blood-brain barrier to methotrexate.
    Barry DI; Paulson OB
    Neurosurgery; 1982 Feb; 10(2):224-6. PubMed ID: 7070618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
    Neuwelt EA; Pagel MA; Kraemer DF; Peterson DR; Muldoon LL
    J Pharmacol Exp Ther; 2004 May; 309(2):594-9. PubMed ID: 14752063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.
    McLemore TL; Liu MC; Blacker PC; Gregg M; Alley MC; Abbott BJ; Shoemaker RH; Bohlman ME; Litterst CC; Hubbard WC
    Cancer Res; 1987 Oct; 47(19):5132-40. PubMed ID: 3621199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA; Rapoport SI
    Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
    Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
    Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
    Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
    Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy.
    Wrobel CJ; Wright DC; Dedrick RL; Youle RJ
    J Neurosurg; 1990 Jun; 72(6):946-50. PubMed ID: 2159988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.